Results 261 to 270 of about 1,680,432 (330)
Some of the next articles are maybe not open access.
The Value of Enteric-Coated Aspirin
New England Journal of Medicine, 1950BECAUSE of its analgesic value, acetylsalicylic acid (aspirin) is used extensively. In the treatment of certain rheumatic disorders, maximal dosage over long periods is frequently necessary if opti...
Marian W. Ropes +2 more
openaire +3 more sources
Enteric-Coated Potassium Supplements
JAMA: The Journal of the American Medical Association, 1974To the Editor.— Despite previous widespread publicity concerning the hazards of enteric-coated potassium supplements, these preparations are still commercially available, prescribed, and dispensed. This was shown recently in a survey that we conducted of 25 pharmacies in the San Francisco metropolitan area.
Bob Berg +3 more
openaire +2 more sources
Self-poisoning with Enteric-coated Aspirin
American Journal of Clinical Pathology, 1983A case of self-poisoning by enteric-coated aspirin tablets is described. Absorption of salicylate was delayed, resulting in serum kinetics different from that obtained with regular aspirin. When the ingested aspirin is enteric coated, the use of Done's nomogram may be inappropriate.
John Baum, John Laczin, Tai C. Kwong
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1974
ABSTRACT To the Editor.— In a letter by Jansen (226:1361, 1973) commenting on the article titled, "Lipoid Pneumonia Caused by Methenamine Mandelate Suspension," by Timmerman and Schroer (225:1524, 1973), it was implied that methenamine mandelate tablets are available only as entericcoated tablets.
openaire +2 more sources
ABSTRACT To the Editor.— In a letter by Jansen (226:1361, 1973) commenting on the article titled, "Lipoid Pneumonia Caused by Methenamine Mandelate Suspension," by Timmerman and Schroer (225:1524, 1973), it was implied that methenamine mandelate tablets are available only as entericcoated tablets.
openaire +2 more sources
The American Journal of Medicine, 1948
Abstract 1.1. Investigations of enteric-coated drugs have shown that some with coatings which claim to "protect the tablet from gastric secretions" fail as well to disintegrate in any other part of the gastrointestinal tract. 2.2. Other preparations disintegrate in the stomach, and in these instances the enteric coating is of no particular value ...
openaire +3 more sources
Abstract 1.1. Investigations of enteric-coated drugs have shown that some with coatings which claim to "protect the tablet from gastric secretions" fail as well to disintegrate in any other part of the gastrointestinal tract. 2.2. Other preparations disintegrate in the stomach, and in these instances the enteric coating is of no particular value ...
openaire +3 more sources
Pharmacokinetics of Enteric-Coated Valproic Acid
Therapeutic Drug Monitoring, 1984Five adult epileptic patients received 1,000 mg of valproic acid (Depakene) in both the regular and the enteric-coated form. Serum valproic acid levels were determined at suitable intervals after drug administration. Pharmacokinetic parameters were equivalent for both preparations except for an absorption lag with the enteric-coated form.
D. Suria, P. S. Albright, J. Bruni
openaire +3 more sources
Evaluation of an Enteric Coated Aspirin Preparation
Australian and New Zealand Journal of Medicine, 1976Summary: Evaluation of an enteric coated aspirin preparation.
G. D. Champion +3 more
openaire +3 more sources
Gastric emptying of enteric-coated tablets
Digestive Diseases and Sciences, 1984To evaluate the gastric emptying time of pharmaceutical dosage forms in a clinical setting, a relatively simple dual-radionuclide technique was developed. Placebo tablets of six different combinations of shape and size were labeled with indium-111 DTPA and enteric coated. Six volunteers participated in a single-blind and crossover study.
B. D. Rosenek +5 more
openaire +3 more sources
Absorption of Enteric-Coated Aspirin
JAMA: The Journal of the American Medical Association, 1983To the Editor.— In Dr Bland's comments (1982;247:2660) on the article entitled "Nonsteroidal Anti-inflammatory Agents in Rheumatoid Arthritis and Ankylosing Spondylitis" by Wasner et al (1981;236:2168), he noted that "there remains doubt that enteric-coated aspirin absorbs with enough predictability to make it worthwhile to use." This criticism of ...
openaire +2 more sources
Enteric Coated Dipropylacetate (Depakine®)
1975Depakine® (sodium di-n-propylacetate, DPA) is a powerful anti-epileptic drug for the treatment of convulsive and non-convulsive generalized epilepsy (Bergamini et al., 1970; de Biolley and Sorel, 1969) as well as for the treatment of focal epilepsy (Meinardi, 1971). It is available in tablets of 300 mg.
G. F. Blom +2 more
openaire +2 more sources